NATR

Nature's Sunshine Products Inc.

Price

$13.17

return (12m)

-22.31%

p/e

12.96

p/bv

1.43

DIVIDEND YIELD

0.00%

NATR price

Nature's Sunshine Products

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment NATR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-10.86%

3 months

-34.19%

1 year

-22.31%

2 years

-6.02%

5 years

-8.87%

10 years

-4.79%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals NATR

Valuation

P/E

12.96

Sector -3.53

Industry -3.53

P/BV

1.43

Sector 2.06

Industry 2.06

P/Revenue (PSR)

0.49

Sector 2.02

Industry 2.02

EV/EBITDA

18.33

Sector -222.67

Industry -222.67

EV/EBIT

29.49

Sector -47.57

Industry -47.57

P/EBITDA

5.74

Sector -21.45

Industry -21.45

P/EBIT

8.41

Sector -28.49

Industry -28.49

P/Total Assets

0.93

Sector 1.20

Industry 1.20

P/Net Current Assets

2.76

Sector -10.32

Industry -10.32

P/Working Capital

2.21

Sector -169.93

Industry -169.93

EPS

1.05

Sector -1.79

Industry -1.79

BVPS

9.51

Sector 2.05

Industry 2.05

Efficiency

Gross Margin

73.16%

Sector 41.30%

Industry 41.30%

EBITDA Margin

7.45%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

4.63%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

5.96%

Sector -35.21%

Industry -35.21%

Net Profit Margins

3.80%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.45

Sector 0.02

Industry 0.02

Profitability

ROE

11.05%

Sector -56.67%

Industry -56.67%

ROA

7.20%

Sector -59.91%

Industry -59.91%

ROIC

12.87%

Sector -2,349.21%

Industry -2,349.21%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

2.60

Sector 2.88

Industry 2.88

Net Debt / EBITDA

-9.46

Sector -14,043,974.86

Industry -14,043,974.86

Net Debt / EBIT

-15.22

Sector -8.02

Industry -8.02

Net Debt / Equity

-0.49

Sector -32,936.86

Industry -32,936.86

Gross Debt / Equity

0.00

Sector -0.84

Industry -0.84

Equity/Assets

0.65

Sector 0.46

Industry 0.46

Liabilities/Assets

0.35

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

2.07%

Sector -

Industry -

5Y Earnings CAGR

-9.14%

Sector -

Industry -

Fundamentals NATR

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Nature's Sunshine Products ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$13.17

Fair Value

$14.99

Upside

13.81%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
NATR Nature's Sunshine Products Inc.	$13.17	-22.31%	0.00%	12.96	1.43	11.05%	3.80%
JNJ Johnson & Johnson	$267.99	54.49%	1.98%	30.47	7.54	24.76%	21.48%
PFE Pfizer Inc.	$27.60	23.23%	6.24%	35.93	1.84	5.11%	6.86%
ABBV AbbVie Inc.	$263.80	25.09%	2.65%	72.22	-76.87	-106.44%	9.81%
NVO Novo Nordisk A/S	$42.06	-22.81%	4.32%	10.50	5.58	53.11%	35.32%
MRK Merck & Co. Inc.	$144.27	85.01%	2.33%	112.32	8.48	7.55%	4.76%
AZN AstraZeneca PLC	$163.87	7.46%	2.03%	19.00	4.89	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$64.10	44.86%	3.96%	13.95	5.80	41.55%	18.85%
ZTS Zoetis Inc.	$73.75	-48.60%	2.89%	11.41	9.59	84.02%	27.77%
AMGN Amgen Inc.	$377.96	41.54%	2.25%	26.93	20.14	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$777.64	35.76%	0.47%	18.62	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$107.82	41.25%	0.00%	30.46	87.77	288.13%	24.86%
MCK McKesson Corporation	$891.74	27.52%	0.37%	19.68	-26.99	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$516.44	31.34%	0.00%	29.63	6.45	21.76%	35.00%
CAH Cardinal Health Inc.	$234.32	57.92%	0.88%	31.71	-20.07	-63.29%	0.68%
ARGX argenx SE	$983.51	29.95%	0.00%	2.61	3.00	114.60%	44.55%
HRMY Harmony Biosciences Holdings Inc.	$42.97	32.22%	0.00%	13.26	2.41	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

NATR Historical Dividends

current DY: 0.00%

5-year average DY: 1.07%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	11/13/2012	11/26/2102	0.05000000
Dividends	03/25/2021	04/09/2021	1.00000000
Dividends	03/20/2017	04/03/2017	0.09470000
Dividends	11/21/2016	12/05/2016	0.09470000
Dividends	08/19/2016	09/02/2016	0.09470000
Dividends	05/23/2016	06/06/2016	0.09470000
Dividends	03/09/2016	03/22/2016	0.09470000
Dividends	11/16/2015	11/30/2015	0.09470000
Dividends	08/21/2015	09/08/2015	0.09470000
Dividends	05/20/2015	06/02/2015	0.09470000
Dividends	03/10/2015	03/23/2015	0.09470000
Dividends	11/18/2014	12/01/2014	0.09470000
Dividends	09/04/2014	09/19/2014	1.50000000
Dividends	08/14/2014	08/29/2014	0.10000000
Dividends	05/19/2014	06/02/2014	0.10000000
Dividends	03/26/2014	04/07/2014	0.10000000
Dividends	11/14/2013	11/29/2013	0.10000000
Dividends	08/15/2013	08/29/2013	1.60000000
Dividends	05/16/2013	05/30/2013	0.10000000
Dividends	03/14/2013	03/28/2013	0.10000000
Dividends	08/09/2012	08/23/2012	0.05000000
Dividends	05/16/2012	05/29/2012	0.05000000

ABOUT Nature's Sunshine Products

Nature's Sunshine Products Inc.

Average Investor10 user rating

4.0 (1 people)

United States

50 years

Founded: 1976

1980

Time since IPO - 46 years

837

Employees

Nature's Sunshine Products Inc. (United States) is listed on the Nasdaq and has a market capitalization of $242.32 million, with shareholders equity totaling $169.32 million.

The company employs approximately 837 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Nature's Sunshine Products Inc. reported $492.02 million in revenue, generating net income of $18.70 million.

Key financial metrics include a P/E ratio of 12.96, a price-to-book (P/B) ratio of 1.43, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NATR.

Market cap

$242.32 million

Net worth

$169.32 million

$169,316,000.00

Assets

$259.82 million

$259,823,000.00

Total Shares Outstanding

17.81 million

17,812,000

Average Daily Trading Volume

$168.70 Thousand

$168,699.78

Sector

Health Care

Industry

Biotechnology

NATR

NATR revenue and profits

Financial Results NATR

DRAG THE FRAME TO SEE MORE DATA

NATR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$891.74 29,25% (12M)

P/E

19.68

0.37%

ROE

-137.16%

P/BV

-26.99

CAH - Cardinal Health

$234.32 59,94% (12M)

P/E

31.71

0.88%

ROE

-63.29%

P/BV

-20.07

JNJ - Johnson & Johnson

$267.99 55,31% (12M)

P/E

30.47

1.98%

ROE

24.76%

P/BV

7.54

ABBV - AbbVie

$263.80 25,88% (12M)

P/E

72.22

2.65%

ROE

-106.44%

P/BV

-76.87

MRK - Merck & Co.

$144.27 84,85% (12M)

P/E

112.32

2.33%

ROE

7.55%

P/BV

8.48

AZN - AstraZeneca

$163.87 7,28% (12M)

P/E

19.00

2.03%

ROE

25.77%

P/BV

4.89

PFE - Pfizer

$27.60 23,59% (12M)

P/E

35.93

6.24%

ROE

5.11%

P/BV

1.84

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$891.74 29,25% (12 M)

P/L

19.68

0.37%

ROE

-137.16%

P/VP

-26.99

CAH - Cardinal Health

$234.32 59,94% (12 M)

P/L

31.71

0.88%

ROE

-63.29%

P/VP

-20.07

JNJ - Johnson & Johnson

$267.99 55,31% (12 M)

P/L

30.47

1.98%

ROE

24.76%

P/VP

7.54

ABBV - AbbVie

$263.80 25,88% (12 M)

P/L

72.22

2.65%

ROE

-106.44%

P/VP

-76.87

MRK - Merck & Co.

$144.27 84,85% (12 M)

P/L

112.32

2.33%

ROE

7.55%

P/VP

8.48

AZN - AstraZeneca

$163.87 7,28% (12 M)

P/L

19.00

2.03%

ROE

25.77%

P/VP

4.89

PFE - Pfizer

$27.60 23,59% (12 M)

P/L

35.93

6.24%

ROE

5.11%

P/VP

1.84

Frequently Asked Questions

What is the price of Nature's Sunshine Products (NATR) today?

A cotação de Nature's Sunshine Products (NATR) hoje está em US$ 13.17, com uma variação de -22.31% em relação ao último ano. A cotação de Nature's Sunshine Products (NATR) iniciou o ano negociando na casa dos US$ 21.58 e hoje está em US$ 13.17. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Nature's Sunshine Products (NATR) e dados de ações do Ibovespa e mercados internacionais.

Quando Nature's Sunshine Products (NATR) paga dividendos?

Nature's Sunshine Products (NATR) não distribuiu dividendos no último ano.

Is Nature's Sunshine Products (NATR) a good investment?

Atualmente, Nature's Sunshine Products (NATR) está cotada a US$ 13.17, com um P/L de 12.96, representando um desvio de 7,489% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -22.31 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -22.31%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Nature's Sunshine Products (NATR) stock?

Investir em ações de Nature's Sunshine Products (NATR) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Nature's Sunshine Products (NATR) yield today?

A rentabilidade de Nature's Sunshine Products (NATR) foi de -10.86% no último mês, -22.31% no último ano e -8.87% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Nature's Sunshine Products (NATR) hoje, o investimento total seria de US$ 1,317.00, com base na cotação atual de US$ 13.17.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 1,023.18
Em 5 anos: US$ 1,200.18
Em 10 anos: US$ 1,253.92

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

NATR

Nature's Sunshine Products Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment NATR

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

COMPARING NATR WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 1.07%

type

Ex - Dividend Date

payment date

value

ABOUT Nature's Sunshine Products

Nature's Sunshine Products Inc.

United States

50 years

1980

837

PROFIT X PRICE NATR

Financial Results NATR

NATR cash flow

Asset, Revenue and Profit Growth - NATR

NATR balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions